These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Carr R; Zed PJ Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568 [TBL] [Abstract][Full Text] [Related]
5. Sulfonylurea intoxication at a tertiary care paediatric hospital. Glatstein M; Garcia-Bournissen F; Scolnik D; Koren G Can J Clin Pharmacol; 2010; 17(1):e51-6. PubMed ID: 20124602 [TBL] [Abstract][Full Text] [Related]
6. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure. Vallurupalli S Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children. Dougherty PP; Lee SC; Lung D; Klein-Schwartz W Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239 [TBL] [Abstract][Full Text] [Related]
8. Octreotide's role in the management of sulfonylurea-induced hypoglycemia. Dougherty PP; Klein-Schwartz W J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540 [TBL] [Abstract][Full Text] [Related]
9. Sulfonylurea-induced hypoglycaemia: use of octreotide. Hanchard B; Boulouffe C; Vanpee D Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242 [TBL] [Abstract][Full Text] [Related]
10. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion. Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935 [TBL] [Abstract][Full Text] [Related]
11. Octreotide for the treatment of hypoglycemia after insulin glargine overdose. Groth CM; Banzon ER J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130 [TBL] [Abstract][Full Text] [Related]
13. Management of sulfonylurea ingestions. Spiller HA Pediatr Emerg Care; 1999 Jun; 15(3):227-30. PubMed ID: 10389964 [TBL] [Abstract][Full Text] [Related]
14. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782 [TBL] [Abstract][Full Text] [Related]
15. Octreotide therapy for nateglinide-induced hypoglycemia. Sherk DK; Bryant SM Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765 [No Abstract] [Full Text] [Related]
16. Octreotide for the treatment of sulfonylurea poisoning. Glatstein M; Scolnik D; Bentur Y Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209 [TBL] [Abstract][Full Text] [Related]
17. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor. Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695 [TBL] [Abstract][Full Text] [Related]